The factor V Leiden mutation and the risk of venous thromboembolism in gynecologic oncology patients

Obstetrics and Gynecology

Volumn 100, Issue 6, 2002, Pages 1285-1289

  Ravin, Amy J ^a,b,c   Edwards, Robert P ^a,b,c   Krohn, Marijane A ^a,b,c   Kelley, Joseph R ^a,b,c   Christopherson, Wayne A ^a,b,c   Roberts, James M ^a,b,c  

^a Grace Hill Neighbor Hlth Ctr Inc   (United States)

^b UNIVERSITY OF LOUISVILLE   (United States)

^c UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 5 LEIDEN; CONTRACEPTIVE AGENT; DNA;

ADULT; AGE; AGED; ARTICLE; BODY MASS; CALCULATION; CANCER STAGING; CANCER THERAPY; CASE CONTROL STUDY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEMOGRAPHY; DISEASE ASSOCIATION; DRUG USE; FEMALE; GYNECOLOGIC CANCER; HUMAN; HYPERCOAGULABILITY; LEUKOCYTE; MUTATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RACE; RISK; RISK ASSESSMENT; SMOKING; THROMBOEMBOLISM; TREATMENT INDICATION;

ADULT; AGED; BASE SEQUENCE; CASE-CONTROL STUDIES; COHORT STUDIES; FACTOR V; FEMALE; GYNECOLOGIC SURGICAL PROCEDURES; HUMANS; INCIDENCE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; MUTATION; NEOPLASMS; POLYMERASE CHAIN REACTION; POSTOPERATIVE COMPLICATIONS; PROGNOSIS; REFERENCE VALUES; RISK ASSESSMENT; THROMBOEMBOLISM;

EID: 0036899933     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0029-7844(02)02320-7     Document Type: Article

References (29)

1. Goldhaber S.Z. Pulmonary embolism. N Engl J Med. 339:1998;93-104.
2. Clarke-Pearson D.L., Synan I.S., Coleman E., Hinshaw W., Creasman W.T. The natural history of postoperative venous thromboemboli in gynecologic oncology A prospective study of 382 patients . Am J Obstet Gynecol. 148:1984;1051-1054.
3. Clark-Pearson D.L., Synan I.S., Hinshaw W.M., Coleman E., Creasman W.T. Prevention of postoperative venous thromboembolism by external pneumatic calf conpression in patients with gynecologic malignancy. Obstet Gyncol. 63:1984;92-98.
4. Jeffcote T.N.A., Tindall V.R. Venous thrombosis and embolism in obstetrics and gynecology. Aust N Z J Obstet Gynaecol. 5:1965;119.
5. Walsh J.J., Bonnar J., Wright F.W. A study of pulmonary embolism and deep leg vein thrombosis after major gynecologic surgery using labeled fibrinogen, phlebography, and lung scanning. J Obstet Gynaecol Br Commonw. 31:1974;311-316.
6. Virchow R. Gesammelte Abhandlungen zur wissenschaftlichen Medizin. 1856;Staatsdruckerei, Frankfurt, Germany.
7. Rees D.C., Cox M., Clegg J.B. World distribution of factor V Leiden. Lancet. 346:1995;1133-1134.
8. Lee D.H., Henderson P.A., Blajchman M.A. Prevalence of factor V Leiden in a Canadian blood donor population. Can Med Assoc J. 155:1996;285-289.
9. Ridker P.M., Hennekens C.H., Lindpainter K., Stampfer M.J., Eisenberg P.R., Miletich J.P. Mutation in the gene coding for coagulation factor V and the risk of myocardial infarction, stroke, and venous thrombosis in apparently healthy men. N Engl J Med. 332:1995;912-917.
10. Rosendaal F.R., Koster T., Vandenbroucke J.P., Reitsma P.H. High risk of thrombosis in patients homozygous for factor V Leiden (activated protein C resistance). Blood. 85:1995;1504-1508.
11. Koster T., Rosendaal F.R., de Ronde H., Vandenbrouke J.P., Bertina R.M. Venous thrombosis due to poor anticoagulant response to activated protein C Leiden thrombophilia study . Lancet. 18:1993;1503-1506.
12. Hillarp A., Zoller B., Dahlback B. Activated protein C Resistenace as a basis for venous thrombosis. Am J Med. 101:1996;534-540.
13. Hellgren M., Svensson P.J., Dahlback B. Resistance to activated protein C as a basis for venous thromboembolism associated with pregnancy and oral contraceptives. Am J Obstet Gynecol. 173:1995;210-213.
14. Hallak M., Senderowicz J., Casse A. Activated protein C resistance (factor V Leiden) associated with thrombosis in pregnancy. Am J Obstet Gynecol. 176:1997;889-893.
15. Bokarewa M.I., Bremme K., Blomback M. Arg 506- Gln mutation in factor V and risk of thrombosis during pregnancy. Br J Haematol. 92:1996;473-478.
16. Gerhardt A., Scharf R.E., Beckmann M.W., Struve S., Bender H.G. Prothrombin and factor V mutations in women with a history of thrombosis during pregnancy and the pueriperium. N Engl J Med. 342:2000;374-380.
17. Dizon-Townsend D.S., Nelson L.M., Jang H., Warner M.W., Ward K. The incidence of the factor V Leiden mutation in obstetrical population and its relation to deep venous thrombosis. Am J Obstet Gynecol. 176:1997;883-886.
18. Bloemenkamp K.W.M., Rosendaal F.R., Helmerhorst F.M., Buller H.R., Vandenbroucke J.P. Enhancement by factor V Leiden mutation of risk of deep vein thrombosis associated with oral contraceptives containing a third generation progestogen. Lancet. 346:1995;1593-1596.
19. Vandenbrouke J.P., Koster T., Briet E., Reitsma R.M., Rosendaal F.R. Increased risk of venous thrombosis in oral contraceptive users who are carriers of factor V Leiden mutation. Lancet. 344:1994;1453-1457.
20. Green K.B., Silverstein R.L. Hypercoagulability in cancer. Hematol Oncol Clin North Am. 1092:1996;499-530.
21. Goodman L.R. CT diagnosis of pulmonary embolism and deep venous thrombosis. Radiographics. 20:2000;1201-1205.
22. Rosenadaal F.R. Venous thrombosis Prevalence and interaction of risk factors . Haemostasis. 29:(Suppl 1):1999;1-9.
23. Phillips M.D. Interrelated risk factors for venous thromboembolism. Circulation. 95:1997;1749-1751.
24. Ridker P.M., Hennekens C.H., Selhub J., Miletich J.P., Malinow M.R., Stampfer M.J. Interrelation of hyperhomocyst(e)inemia, factor V Leiden and the risk of future venous thromboembolism. Circulation. 95:1997;1777-1782.
25. Green D., Maliekel K., Sushko E., Akhtar R., Soff G.A. Activated protein C resistance in cancer patients. Haemostasis. 27:1997;112-118.
26. Sifontes M., Nuss R., Hunger S.P., Wilimas J., Jacobson L.J. The factor V Leiden mutation in children with cancer and thrombosis. Br J Haematol. 96:1997;484-489.
27. Otterson G.A., Monahan B. P, Harold N, Steinberg JN, Kaye FJ. Clinical significance of the FV:Q 506 mutation in unselected oncology patients. Am J Med. 101:1996;406-412.
28. Haim N., Lanir N., Hoffman R., Haum A., Tsalik M., Brenner B. Acquired activated protein C resistance is common in cancer patients and is associated with venous thromboembolism. Am J Med. 110:2001;91-96.
29. De Lucia D., De Vita F., Orditura M., Renis V., Belli A., Conte M., et al. Hypercoagulable state in patients with advanced gastrointestinal cancer Evidence for an acquired resistance to activated protein C . Tumori. 83:1997;948-952.